While representatives of the European Parliament and the Council of the European Union are just beginning negotiations on the draft regulation for a strengthened role for the European Medicines Agency (EMA), approximately thirty organisations, research centres and universities are mobilising to obtain guarantees on the transparency of clinical trials.
These stakeholders, who have come together under the ‘European Alliance for Responsible R&D and Affordable Medicines’, wrote to Member...